Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Payables: 2020-2025

Historic Payables for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $62.5 million.

  • Cellebrite DI's Payables rose 580.38% to $62.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.7 million, marking a year-over-year increase of 185.21%. This contributed to the annual value of $63.3 million for FY2024, which is 41.22% up from last year.
  • Cellebrite DI's Payables amounted to $62.5 million in Q3 2025, which was down 8.07% from $68.0 million recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's Payables peaked at $68.0 million during Q2 2025, and registered a low of -$11.1 million during Q1 2022.
  • For the 3-year period, Cellebrite DI's Payables averaged around $32.7 million, with its median value being $43.5 million (2023).
  • Per our database at Business Quant, Cellebrite DI's Payables plummeted by 100.50% in 2022 and then surged by 671.68% in 2025.
  • Quarterly analysis of 5 years shows Cellebrite DI's Payables stood at $54.0 million in 2021, then fell by 15.90% to $45.5 million in 2022, then decreased by 1.34% to $44.8 million in 2023, then spiked by 41.22% to $63.3 million in 2024, then surged by 580.38% to $62.5 million in 2025.
  • Its Payables stands at $62.5 million for Q3 2025, versus $68.0 million for Q2 2025 and $53.9 million for Q1 2025.